Volume 2, issue 1, February 2001

44 articles in this issue

Diabetic AMI patients receive suboptimal thrombolytic treatment

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 19 October 2001
- Article: 72161
Tamoxifen is not associated with increased CV event rate

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 19 October 2001
- Article: 72160
Antioxidant effect of estrogen may protect heart cells from inflammation

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 19 October 2001
- Article: 72158
Long-term weight loss lowers BP in mildly hypertensive overweight patients

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 19 October 2001
- Article: 72157
Patients with AMI continue to delay hospital presentation

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 19 October 2001
- Article: 72155
'No independent link' between diabetes and poor outcomes after CABG/PTCA

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 19 October 2001
- Article: 72154
Statins reduce dementia risk by 70%

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 19 October 2001
- Article: 72150
Caerphilly study finds no link between homocysteine and CHD

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 18 October 2001
- Article: 72106
Prognostic value of ultrasonographic measurements in stable angina

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 18 October 2001
- Article: 72105
Risk of intraparenchymal stroke increased by low saturated fat intake in women

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 18 October 2001
- Article: 72104
Diastolic dysfunction as predominant form of CHF confirmed

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 18 October 2001
- Article: 72103
Noninvasive tests for CAD unsuitable in renal failure patients

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 18 October 2001
- Article: 72102
Diabetes and insulin use on AMI survival - is enough being done?

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 18 October 2001
- Article: 72101
Coronary event risk needs to be quantified before advising aspirin for primary prevention

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 18 October 2001
- Article: 72100
Sudden vigorous exercise associated with increased risk of death

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 18 October 2001
- Article: 72062
Evidence for increased risk of venous thrombosis during air travel

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 18 October 2001
- Article: 72061
Different mechanisms by which CMV predisposes to CAD in men and women

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 18 October 2001
- Article: 72060
Plaque morphology directly related to platelet activation in ACS

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 18 October 2001
- Article: 72059
Multi-drug risk reduction strategy safe in peripheral artery disease

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 18 October 2001
- Article: 72058
Preinfarction angina protects against in-hospital adverse outcomes in the elderly

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 18 October 2001
- Article: 72057
Community-based study highlights sex differential in post-MI mortality

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 18 October 2001
- Article: 72056
More evidence for inflammatory markers in predicting CHD risk

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 18 October 2001
- Article: 72055
Epifibatide is justified in community hospital treatment of ACS

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 18 October 2001
- Article: 72054
Statins not effective in reducing osteoporotic fractures

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 18 October 2001
- Article: 72053
Lack of effect of HRT on stroke/TIA risk 'not surprising'

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 18 October 2001
- Article: 72052
Tamoxifen may reduce CHD risk via inflammatory mediators

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 18 October 2001
- Article: 72051
Major study finds no link between gum disease and CV risk

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 18 October 2001
- Article: 72050
Metoprolol vs carvedilol in heart failure

Authors
- Michael Norton
- Content type: Paper Report
- Published: 17 October 2001
- Article: 72005
Intravenous dofetilide vs amiodarone

Authors
- Niall Mulvahill
- Content type: Paper Report
- Published: 17 October 2001
- Article: 72003
Amiodarone as a first choice drug

Authors
- Niall Mulvahill
- Content type: Paper Report
- Published: 17 October 2001
- Article: 72002
Effects of alcohol consumption in patients with left ventricular dysfunction

Authors
- T Irvine
- Content type: Paper Report
- Published: 17 October 2001
- Article: 72001
Dietary changes take two years to reduce heart attack risk

Authors
- Joanna Lyford
- Content type: Paper Report
- Published: 17 October 2001
- Article: 71954
Orbofiban in unstable angina (OPUS-TIMI 16 trial)

Authors
- Gethin Ellis
- Content type: Paper Report
- Published: 17 October 2001
- Article: 71901
Intracoronary radiation for in-stent restenosis

Authors
- Mehrdad Malenkianpoor
- Content type: Paper Report
- Published: 17 October 2001
- Article: 71900
Experience collecting interim data on mortality: an example from the RALES study

Authors (first, second and last of 9)
- Janet Wittes
- Jolie Palensky
- Barbara Roniker
- Content type: Research
- Published: 07 February 2001
- Article: 59
New immunosuppressive drugs in heart transplantation

Authors
- Maria Rosa Costanzo
- Content type: Review
- Published: 08 February 2001
- Article: 45
Use of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trials

Authors
- Steven Warach
- Content type: Review
- Published: 30 January 2001
- Article: 38
The current status of primary prevention in coronary heart disease

Authors
- Cornel Pater
- Content type: Review
- Published: 30 January 2001
- Article: 24
The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial

Authors
- Eric J Eichhorn
- Michael R Bristow
- Content type: Commentary
- Published: 02 February 2001
- Article: 20
The Proliferation REduction with Vascular ENergy Trial (PREVENT)

Authors
- Albert E Raizner
- Grzegorz L Kaluza
- Content type: Commentary
- Published: 01 February 2001
- Article: 16
Debate: "How low should LDL cholesterol be lowered for optimum prevention of vascular disease?" Viewpoint: "Below 100 mg/dl"

Authors
- W Virgil Brown
- Content type: Commentary
- Published: 09 February 2001
- Article: 12
Debate: "How low should LDL cholesterol be lowered?" Viewpoint: "It doesn't need to be very low"

Authors
- Sergio Fazio
- MacRae F Linton
- Content type: Commentary
- Published: 30 January 2001
- Article: 8
Fundamental deficiencies in the megatrial methodology

Authors
- Bruce G Charlton
- Content type: Commentary
- Published: 30 January 2001
- Article: 2
Are there fundamental deficiencies in the megatrial methodology?

Authors
- Desmond Julian
- Curt Furberg
- Content type: Editorial
- Published: 09 February 2001
- Article: 1

Volume 2, issue 1, February 2001

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors (first, second and last of 9)

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

For authors

Explore

Search

Navigation